All News #Library
Rare Diseases
Biocryst Expands Rare Diseases Focus In $700M Astria Deal
14 Oct 2025 //
FIERCE BIOTECH
EU Grants Orphan Designation For Navenibart In Hereditary Angioedema
16 Oct 2024 //
BUSINESSWIRE

Market Place
Sourcing Support